What are the contraindications to naltrexone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Contraindications to Naltrexone

The absolute contraindication to naltrexone is current opioid use, including prescribed opioid analgesics, as it will precipitate severe opioid withdrawal. 1

Absolute Contraindications

Based on the most recent 2026 British Association for Psychopharmacology guidelines and FDA labeling, naltrexone is contraindicated in:

  • Current opioid use (including prescribed opioid analgesia) 2, 1
  • Current opioid dependence, including patients maintained on:
    • Methadone 1
    • Buprenorphine 1
  • Acute opioid withdrawal 1
  • Positive urine screen for opioids 1
  • Failed naloxone challenge test 1
  • Known hypersensitivity to naltrexone or any product components 1

Critical Timing Considerations

Patients must be opioid-free for at least 7 days before starting naltrexone to avoid precipitating severe withdrawal. 2, 1 This is a safety-critical requirement that directly impacts morbidity.

Special Opioid Situations

For patients who received long-acting buprenorphine within the past 12 months, naltrexone is best avoided entirely, as it may precipitate withdrawal even after extended opioid-free periods. 2

Relative Contraindications and Cautions

Hepatic Impairment

The evidence on hepatic contraindications has evolved significantly:

  • Child-Pugh B and C cirrhosis or acute alcoholic hepatitis: Use with caution due to risk of accumulation of naltrexone's active metabolites 2
  • Historical hepatotoxicity concerns have been challenged - naltrexone may be used in patients with alcohol-associated liver disease 2
  • Dose-related hepatotoxicity occurs only at doses much higher (up to 300 mg/day) than the standard 50 mg/day dose 1

Procedural Planning

Naltrexone must be discontinued before any procedure requiring opioid analgesia (e.g., endoscopies using fentanyl), as it will block the analgesic effect. 3 This is a practical consideration that affects quality of life and procedural safety.

Common Clinical Pitfalls

  1. Failing to verify opioid-free status: Always confirm patients are truly opioid-free for ≥7 days before initiation
  2. Overlooking prescribed opioids: Many patients don't consider their prescribed pain medications as "opioids"
  3. Inadequate washout from long-acting buprenorphine: Standard 7-day washout is insufficient for long-acting formulations
  4. Not planning for surgical/procedural needs: Patients may require opioid analgesia unexpectedly

Not Contraindications (Important Clarifications)

  • Alcohol-associated liver disease: Generally safe to use 2
  • Renal impairment: Unlike acamprosate, naltrexone has no specific renal contraindications mentioned in guidelines
  • Depression or suicidal ideation: While monitoring is needed, these are not contraindications 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.